Phase II & III Services

Clinilabs offers a full range of Phase II and III clinical development services. We specialize in managing multi center Phase II studies in a wide range of therapeutic areas with a focus on CNS, cardiovascular, and metabolic studies conducted at investigator sites on five continents.

Our team has experience in over 1,000 clinical trials in the following therapeutic areas:

  • Infectious Disease: HIV, Hepatitis C
  • Cardiology: Heart Failure, Hypertension, Hypotension, Hypercholesterolemia
  • Oncology
  • Endocrine and Metabolic: Diabetes, Obesity, Binge Eating
  • Neurological Disorders: Parkinson’s Disease, Epilepsy, Alzheimer’s Disease, Traumatic Brain Injury
  • Psychiatric Disorders: Depression, Bipolar Disorder, Schizophrenia, Generalized Anxiety Disorder
  • Pain and Inflammation: Osteoarthritis, Rheumatoid Arthritis
  • Pulmonary Disease: Asthma, COPD 
  • Dermatology: Psoriasis, Rheumatoid Arthritis
  • Rare Disorders: Congenital Blindness, Hereditary Inclusion Body Myopathy, Narcolepsy, Symptomatic Orthostatic Hypotension
  • Sleep Disorders: Insomnia, Sleep Apnea, Narcolepsy, Idiopathic Hypersomnia, Restless Legs Syndrome, Shift Work Sleep Disorder, Jet Lag, Non-24 Hour Sleep Wake Rhythm Disorder
  • Sexual and Reproductive Disorders: Male Erectile Dysfunction
  • Women’s Health: Menopause



Click HERE to download our Multicenter, Full Service CRO Case Study.